ReviewTherapeutics and clinical risk management2021

Current Opinion on Pixantrone in the Treatment of Non-Hodgkin B-Cell Lymphoma.

Barbara Jezeršek Novaković et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.